Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Gregor

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Alimentary Pharmacology & Therapeutics|December 21, 2018
Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapiesChristopher Ma, Leonardo Guizzetti, Lauren E Cipriano, et al.
Clinical and Translational Gastroenterology|April 6, 2021
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort StudyAze Wilson, Qian Wang, Yun-Hee Choi, et al.
Clinical and Translational Gastroenterology|January 21, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort StudyEryn Rooney, Gio R Dela Cruz, Terry Ponich, et al.
Journal of Clinical Epidemiology|April 30, 2014
Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, CanadaEric I Benchimol, Astrid Guttmann, David R Mack, et al.
Pharmacogenetics and Genomics|April 21, 2026
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel diseaseMohammed Alkhalifa, Gio R Dela Cruz, Terry Ponich, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2025
IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel DiseaseNavneet Natt, Monica Gindi, Gio R Dela Cruz, et al.
Inflammatory Bowel Diseases|October 31, 2019
Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel DiseaseSaleh Al Draiweesh, Christopher Ma, Maan Alkhattabi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Alimentary Pharmacology & Therapeutics|December 21, 2018
Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapiesChristopher Ma, Leonardo Guizzetti, Lauren E Cipriano, et al.
Clinical and Translational Gastroenterology|April 6, 2021
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort StudyAze Wilson, Qian Wang, Yun-Hee Choi, et al.
Clinical and Translational Gastroenterology|January 21, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort StudyEryn Rooney, Gio R Dela Cruz, Terry Ponich, et al.
Journal of Clinical Epidemiology|April 30, 2014
Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, CanadaEric I Benchimol, Astrid Guttmann, David R Mack, et al.
Pharmacogenetics and Genomics|April 21, 2026
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel diseaseMohammed Alkhalifa, Gio R Dela Cruz, Terry Ponich, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2025
IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel DiseaseNavneet Natt, Monica Gindi, Gio R Dela Cruz, et al.
Inflammatory Bowel Diseases|October 31, 2019
Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel DiseaseSaleh Al Draiweesh, Christopher Ma, Maan Alkhattabi, et al.
Pageof 2